528118 Sigma-AldrichPI 3-Kδ Inhibitor X, IC87114 - CAS 371242-69-2 - Calbiochem
PI 3-Kδ Inhibitor X, IC87114, CAS 371242-69-2, is a cell permeable, selective inhibitor of PI 3-Kδ (IC50= 1.82, 0.07, and 1.24 for p110, p110, and p110, respectively).
More>> PI 3-Kδ Inhibitor X, IC87114, CAS 371242-69-2, is a cell permeable, selective inhibitor of PI 3-Kδ (IC50= 1.82, 0.07, and 1.24 for p110, p110, and p110, respectively). Less<<Synonyms: Phosphatidylinositol 3-Kinase p110d Inhibitor, PI 3-K Inhibitor X
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
371242-69-2 | C₂₂H₁₉N₇O |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
528118-5MG |
|
5 mg |
|
— |
References | |
---|---|
References | Billottet, C., et al. 2009. Cancer Res. 69,1027. Ali, K., et al. 2008. J. Immunol. 180, 2538. |
Product Information | |
---|---|
CAS number | 371242-69-2 |
Form | White powder |
Hill Formula | C₂₂H₁₉N₇O |
Chemical formula | C₂₂H₁₉N₇O |
Structure formula Image | |
Quality Level | MQ100 |
Applications | |
---|---|
Application | PI 3-Kδ Inhibitor X, IC87114, CAS 371242-69-2, is a cell permeable, selective inhibitor of PI 3-Kδ (IC50= 1.82, 0.07, and 1.24 for p110, p110, and p110, respectively). |
Biological Information | |
---|---|
Purity | ≥95% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
528118-5MG | 04055977197013 |
Documentation
PI 3-Kδ Inhibitor X, IC87114 - CAS 371242-69-2 - Calbiochem SDS
Title |
---|
PI 3-Kδ Inhibitor X, IC87114 - CAS 371242-69-2 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
528118 |
References
Reference overview |
---|
Billottet, C., et al. 2009. Cancer Res. 69,1027. Ali, K., et al. 2008. J. Immunol. 180, 2538. |